eye disorder
eye disorder
Explore linked clinical trials. Standard reference: MONDO:00053282,564 results · Page 1 of 103
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| OCTA Evaluated the Efficacy of Glucocorticoid Retrobulbar Injection in Retinal Photo-injury | Craniocerebral Trauma, Eye Burns, Eye Injuries, Facial Injuries, Foveomacular Retinitis, eye disorder, injury, nervous system disorder, nervous system injury, radiation injury, retinal disorder | Recruiting | Not stated | 2026-10-09 | NCT07869511 | |
| Trabeculectomy Versus MicroShunt Implantation in Glaucoma Surgery (TIGER) | eye disorder, glaucoma, ocular hypertension | Not yet recruiting | Not applicable | 2026-10-09 | NCT07869108 | |
| Evaluation of Ophtholic Ultra for Ocular Surface Protection After Cataract Surgery | dry eye syndrome, eye disorder, lacrimal apparatus disorder | Active, not recruiting | Phase 4 | 2026-10-09 | NCT07868965 | |
| A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of NIO752 in Primary Tauopathies | Frontotemporal Lobar Degeneration, Neurologic Manifestations, Nutritional and Metabolic Diseases, Ocular Motility Disorders, Pathological Conditions, Signs and Symptoms, Pick disease, Signs and Symptoms, TDP-43 proteinopathy, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, corticobasal degeneration disorder, cranial nerve neuropathy, dementia, eye disorder, frontotemporal dementia, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, ophthalmoplegia, palsy, progressive supranuclear palsy, proteostasis deficiencies, psychiatric disorder, tauopathy | Not yet recruiting | Phase 2 | 2026-10-09 | NCT07868328 | |
| Factors Influencing Corneal Donation in Palliative Care Unit | corneal disorder, eye disorder | Recruiting | Not stated | 2026-10-09 | NCT07868198 | |
| Phase 3 Study of Intravitreal 4D-150 in Adults With Diabetic Macular Edema (DME) (4D-150-C005) | eye disorder | Recruiting | Phase 3 | 2026-10-09 | NCT07867080 | |
| Pain Phenotyping of Rheumatic Diseases - An Observational Study | Axial Spondyloarthritis, Infections, Neuroinflammatory Diseases, Sjogren syndrome, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, Stomatognathic Diseases, Xerostomia, ankylosing spondylitis, ankylosis, arthritic joint disease, arthropathy, autoimmune disease, autoimmune disorder of the nervous system, bone disorder, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system infectious disorder, central nervous system lupus, central nervous system vasculitis, cerebrovascular disorder, connective tissue disorder, dry eye syndrome, encephalitis, eye disorder, immune system disorder, lacrimal apparatus disorder, meningitis, meningoencephalitis, mouth disorder, musculoskeletal system disorder, nervous system disorder, rheumatic disorder, rheumatoid arthritis, salivary gland disorder, spondylitis, systemic lupus erythematosus, vascular disorder, vasculitis, vertebral column disorder, viral infection of central nervous system | Not yet recruiting | Not stated | 2026-10-09 | NCT07829497 | |
| Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction | Chandler syndrome, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Corneal Endothelial Cell Loss, Corneal Endothelial Dystrophy 1, Eye Diseases, Hereditary, Eye Manifestations, Fuchs' endothelial dystrophy, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Signs and Symptoms, congenital hereditary endothelial dystrophy of cornea, corneal disorder, corneal dystrophy, corneal edema, eye disorder, hereditary disease | Recruiting | Phase 2 | 2026-10-09 | NCT07729137 | |
| A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005) | Diabetes Complications, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorder, vascular disorder | Recruiting | Phase 3 | 2026-10-09 | NCT07705607 | |
| A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004) | Diabetes Complications, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorder, vascular disorder | Recruiting | Phase 3 | 2026-10-09 | NCT07705555 | |
| Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration | eye disorder, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT07587515 | |
| The Progressive Supranuclear Palsy Clinical Trial Platform | Neurologic Manifestations, Ocular Motility Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, basal ganglia disorder, brain disorder, central nervous system disorder, cranial nerve neuropathy, eye disorder, movement disorder, nervous system disorder, neurodegenerative disease, ophthalmoplegia, palsy, tauopathy | Recruiting | Phase 2 | 2026-10-09 | NCT07173803 | |
| MHB018A Treatment in Patients With Active Thyroid Eye Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorder | Active, not recruiting | Phase 3 | 2026-10-09 | NCT06989918 | |
| A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma | Glaucoma, Primary Open Angle, eye disorder, glaucoma, ocular hypertension, open-angle glaucoma | Recruiting | Phase 3 | 2026-10-09 | NCT06822738 | |
| Electrical Stimulation for Vision Neuroenhancement in Glaucoma | eye disorder, glaucoma, ocular hypertension, open-angle glaucoma | Recruiting | Not applicable | 2026-10-09 | NCT06685211 | |
| Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Juvenile Macular Degeneration, Stargardt Disease 1, Stargardt disease, cone-rod dystrophy, eye disorder, hereditary disease, inherited retinal dystrophy, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Not stated | 2026-10-09 | NCT06445322 | |
| Hyperbaric Oxygen Therapy for Optic Neuropathies | cranial nerve neuropathy, eye disorder, glaucoma, nervous system disorder, ocular hypertension, optic nerve disorder | Recruiting | Not applicable | 2026-10-09 | NCT06128720 | |
| Electrical Stimulation for the Treatment of Glaucoma | eye disorder, glaucoma, ocular hypertension, open-angle glaucoma | Active, not recruiting | Not applicable | 2026-10-09 | NCT05626491 | |
| Transconjunctival Versus Transcutaneous Betamethasone for Upper Eyelid Retraction in TED | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorder | Not yet recruiting | Not applicable | 2026-10-08 | NCT07866261 | |
| OCT Macula Biomarkers Before Silicone Oil Removal and Visual Outcome After Silicone Oil Removal | eye disorder, macular degeneration, macular retinal edema, preretinal fibrosis, retinal degeneration, retinal detachment, retinal disorder | Not yet recruiting | Not stated | 2026-10-08 | NCT07865468 | |
| Effectiveness of an Oral Exercise Program for Xerostomia in Patients With Sjögren Disease | Sjogren syndrome, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Xerostomia, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, dry eye syndrome, eye disorder, immune system disorder, lacrimal apparatus disorder, mouth disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis, salivary gland disorder | Not yet recruiting | Not applicable | 2026-10-08 | NCT07864987 | |
| Natural History Study of Advanced RCD | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Rod-Cone Dystrophy, cone-rod dystrophy, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosa | Recruiting | Not applicable | 2026-10-08 | NCT07854899 | |
| Contact Lens-Wearing Dry Eye Subjects Who Are Treated With Acoltremon 0.003% | dry eye syndrome, eye disorder, lacrimal apparatus disorder | Not yet recruiting | Phase 4 | 2026-10-08 | NCT07848373 | |
| Evaluation of a Scalable Educational Intervention for Adjustment and Coping to Vision Loss | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, eye disorder, nervous system disorder, vision disorder | Enrolling by invitation | Not applicable | 2026-10-08 | NCT07715695 | |
| Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema | Diabetes Complications, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, retinal disorder, vascular disorder | Recruiting | Phase 2 / Phase 3 | 2026-10-08 | NCT07592273 |